Skip to search formSkip to main contentSkip to account menu

Etoposide/Ifosfamide regimen

Known as: EIM, IFF/VP-16, ifosfamide etoposide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An EIM (ethanol infusion into the vein of Marshall [VOM]) provoked a fatal complication in a chronic hemodialysis patient… 
2015
2015
BACKGROUND Anti-tumour necrosis factor [anti-TNF] treatment was demonstrated to have disease-modifying abilities in inflammatory… 
Review
2015
Review
2015
BackgroundInflammatory bowel diseases (IBDs) are a group of chronic diseases affecting the gastrointestinal tract, with a… 
2013
2013
Acral erythema (palmoplantar erythrodysesthesia) is a localized skin side effect that is seen most often in patients receiving… 
2008
2008
Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with… 
2006
2006
We report on a three-drug myeloablative regimen designed to consolidate remission and to prevent central nervous system (CNS… 
Review
2004
Review
2004
BACKGROUND To assess the extent of gastric intestinal metaplasia (IM) in gastrectomy specimens in populations of the Pacific… 
Review
1995
Review
1995
The purpose of this study was to determine activity of etoposide-platin combination chemotherapy for chemorefractory gestational… 
1994
1994
1989
1989
ProMACE CytaBOM, a polychemotherapy regimen consisting of cyclophosphamide, doxorubicin, etoposide cytozar, bleomycin…